CollPlant Biotechnologies... (CLGN)
3.34
0.20 (6.37%)
At close: Mar 07, 2025, 3:43 PM
3.04
-8.95%
After-hours: Mar 06, 2025, 02:03 PM EST
CollPlant Biotechnologies Ltd. Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 26.67M | 29.65M | 13.15M | 3.33M | 3.79M | 5.33M | 5.13M | 987.11K | 1.36M | 2.84M | 6.83M | 2.76M |
Short-Term Investments | n/a | n/a | 30.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 188K | 213K | 181K | 168K | 173K | 171.39K | 188.38K | 163.97K | n/a | n/a | n/a |
Other Long-Term Assets | 57K | 188K | 213K | 181K | n/a | 172.06K | 171.19K | 188.48K | 163.44K | 158.19K | 163.68K | -1.25M |
Receivables | 393K | 9K | 270K | 830K | 79K | 516K | 102.02K | 949.42K | 468.53K | 355.42K | 447.38K | n/a |
Inventory | 714K | 1.43M | 1.08M | 1.26M | 888K | 810.37K | 201.4K | 126.61K | 1.00 | 2.00 | 1.00 | n/a |
Other Current Assets | 241K | 566K | 437K | 251K | 282K | 334K | 1.03M | 68.11K | 361.71K | 42.12K | 19.48K | 848.51K |
Total Current Assets | 28.02M | 31.66M | 45.09M | 5.68M | 5.04M | 7.14M | 6.45M | 2.1M | 2.19M | 3.24M | 7.32M | 3.57M |
Property-Plant & Equipment | 5.86M | 5.68M | 5.68M | 4.9M | 5.54M | 1.4M | 1.03M | 1.04M | 669.12K | 515.42K | 706.96K | 782.87K |
Goodwill & Intangibles | 188K | 245K | 243K | 82K | n/a | 338.01K | 418.35K | 424.01K | 440.87K | 443K | 498.49K | 469.24K |
Total Long-Term Assets | 6.1M | 6.11M | 6.14M | 5.17M | 5.71M | 1.91M | 1.62M | 1.65M | 1.27M | 1.12M | 1.37M | 1.25M |
Total Assets | 34.13M | 37.77M | 51.22M | 10.84M | 10.75M | 9.05M | 8.07M | 3.75M | 3.47M | 4.35M | 8.69M | 5M |
Account Payables | 980K | 1.13M | 1.03M | 798K | 833K | 622K | 840.72K | 1.35M | 639.4K | 421.68K | 532.95K | 450.76K |
Deferred Revenue | n/a | n/a | 32K | 207K | 942K | 965.43K | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 624K | 1.06M | 1.04M | 880K | 479K | 22K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.65M | 914K | 910K | 1.5M | 1.2M | 1.59M | 574.29K | 420.37K | 321.24K | 258.09K | 382.77K | 347.11K |
Total Current Liabilities | 3.25M | 3.1M | 3.01M | 3.39M | 3.46M | 2.23M | 1.42M | 1.77M | 960.64K | 679.77K | 915.72K | 797.87K |
Long-Term Debt | 2.54M | 2.38M | 3.09M | 2.95M | 3.14M | 22K | 3.64M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 28K | 68K | 1.08M | 404.25K | 641.35K | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 2.54M | 2.38M | 3.09M | 2.98M | 3.21M | 2.05M | 4.04M | 641.35K | n/a | n/a | n/a | n/a |
Total Liabilities | 5.79M | 5.49M | 6.1M | 6.36M | 6.66M | 4.29M | 5.46M | 2.41M | 960.64K | 679.77K | 915.72K | 797.87K |
Total Debt | 3.16M | 2.91M | 3.61M | 3.39M | 3.62M | 44.61K | 3.64M | n/a | n/a | n/a | n/a | n/a |
Common Stock | 4.98M | 4.87M | 4.66M | 2.93M | 2.37M | 1.52M | 1.44M | 833.72K | 682.69K | 619.94K | 680.26K | 406.3K |
Retained Earnings | -96.74M | -89.72M | -72.8M | -73.03M | -67.26M | -49.03M | -50.17M | -41.05M | -34.22M | -30.57M | -30.5M | -24.16M |
Comprehensive Income | -969K | -969K | -969K | -969K | -969K | -2.84M | -2.7M | -2.22M | -1.99M | -1.79M | -1.79M | n/a |
Shareholders Equity | 28.34M | 32.28M | 45.12M | 4.48M | 4.09M | 4.76M | 2.61M | 1.34M | 2.51M | 3.68M | 7.78M | 4.2M |
Total Investments | 57K | 188K | 30.15M | 181K | 168K | 173K | 171.39K | 188.38K | 163.97K | n/a | n/a | n/a |